SS Innovations International (SSII) FCF Margin (2022 - 2026)
SS Innovations International's (SSII) quarterly FCF Margin came in at 21.31% in Q1 2026, up 11492.0% year-on-year from N/an in Q1 2025, and up 4.21% quarter-over-quarter from 22.25% in Q4 2025.
SS Innovations International (SSII) FCF Margin (2022 - 2026) Analysis & Trends
SS Innovations International has disclosed FCF Margin across 5 years of filings, most recently posting 21.31% for Q1 2026.
- FCF Margin for Q1 2026 came in at 21.31%, up 11492.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 36.3% (up 2850.0% YoY), and the FY2025 annual result was 52.26%, down 303.0% from the prior year.
- FCF Margin came in at 21.31% for Q1 2026 at SS Innovations International, up from 22.25% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 19.24% in Q3 2024 to a low of 690.75% in Q1 2023.
- The 5-year median for FCF Margin is 76.95% (2024), against an average of 173.56%.
- Across the five-year window, FCF Margin jumped 61380 bps in 2024 and tumbled 5929 bps in 2025, its largest moves.
- SS Innovations International's FCF Margin stood at 313.04% in 2022, then decreased by 1 bps to 316.96% in 2023, then jumped by 87 bps to 41.73% in 2024, then jumped by 47 bps to 22.25% in 2025, then grew by 4 bps to 21.31% in 2026.
- The last three FCF Margin figures came in at 21.31% (Q1 2026), 22.25% (Q4 2025), and 64.09% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.44% |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | -21.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.31% |
| Dec 31, 2025 | -22.25% |
| Sep 30, 2025 | -64.09% |
| Jun 30, 2025 | -37.69% |
| Mar 31, 2025 | -136.24% |
| Dec 31, 2024 | -41.73% |
| Sep 30, 2024 | -19.24% |
| Jun 30, 2024 | -69.51% |
| Mar 31, 2024 | -76.95% |
| Dec 31, 2023 | -316.96% |
| Sep 30, 2023 | -265.75% |
| Jun 30, 2023 | -154.64% |
| Mar 31, 2023 | -690.75% |
| Dec 31, 2022 | -313.04% |
| Sep 30, 2022 | -373.27% |